Purpose. A possible role for fondaparinux as a bridging agent in the perioperative setting is explored. Summary. Anticoagulation guidelines provide minimal direction on the perioperative use of ...
Are fondaparinux (Arixtra) injections preferable to warfarin (Coumadin) for management of anticoagulation in postoperative hip-fracture patients and those recovering from joint replacement surgery?
HYDERABAD, India & BRISBANE, Australia--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has received final ...
In patients with NSTE ACS, fondaparinux was not inferior to enoxaparin in reducing the occurrence of death, MI or refractory ischemia at 9 days, and was superior to enoxaparin in reducing death and ...
LONDON, Sept 3 (Reuters) - GlaxoSmithKline Plc said on Monday that European regulators had approved its anti-clot treatment Arixtra for specific acute coronary syndromes (ACS). ACS conditions affect ...
Mylan Ireland Limited has entered into an agreement to acquire the U.S. rights to Aspen Global’s Arixtra Injection. Arixtra is indicated for the prophylaxis of deep vein thrombosis. Mylan will pay ...
SAN FRANCISCO (MarketWatch) -- GlaxoSmithKline plc said Monday the supplemental new drug application for its anticoagulant drug candidate Arixtra has been accepted for priority review by the Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results